Description

Anticoagulant, including various products, is mainly used to prevent blood clotting. It will also be used when patients need to connect to some medical instruments or receive blood transfusions or when their blood needs to be sent for testing. Through the use of anticoagulant, diseases caused by blood clots like deep venous thrombosis, pulmonary embolism, myocardial infarction and stroke can be avoided.

View Full Report at: http://www.marketresearchreports.biz/analysis/294338

With the ageing population and the increased incidence of cardiovascular diseases, current gold standard anticoagulants have become unable to satisfy the treatment demand. It is inevitable for improved drugs to come into the market. Warfarin and heparin which have monopolized the anticoagulant market for over half a century will gradually be replaced by the new generation of direct thrombin inhibitor and Xa factor inhibitor and finally fade out.

The representative varieties of thrombin are as follows: hirudin, recombinant hirudin, bivalirudin, argatroban and dabigatran etexilate. Direct thrombin inhibitor brought in a sales value of USD 2.4 billion in 2013, ranking third among anti-clotting drugs. And it occupied 10.4% of the total sales value of anti-clotting drugs while dabigatran etexilate accounted for 73.6% of the sum. According to CRI’s survey, the sales value of thrombin in China rose from CNY 13 million in 2005 to CNY 20.77 million in 2014 with CAGR during this period reaching about 5.6%. Currently, major manufacturers of thrombin in the Chinese market are Changchun Guoao Pharmaceutical Co., Ltd, Biochemical Pharmaceutical Factory of Zhuhai S. E. Z., Hunan Yige Pharmaceutical Co., Ltd, Hacon Pharma and Wuxi Kaifu Pharmaceutical Co., Ltd.

Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/294338

With the change of life styles and ageing population, the incidence of cardiovascular disease is expected to keep increasing in the next few years in China, driving the market size of thrombin to expand further.



Readers can get at least the following information from this report:

market size of thrombin in China
competitive landscape of thrombin in Chinese market
price of thrombin made by different enterprises in China
market outlook of thrombin in China

The author suggests the following groups of people purchase this report:

manufacturers of anticoagulants
investors/ research institutions interested in Chinese medicine market
any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Content

1 Related Concepts of Thrombin
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Thrombin in China
2.1 Patent and Approval Status of Thrombin in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Thrombin in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions


Browse all latest Articles of Market Research Reports
at:http://www.marketresearchreports.biz/articles


About us

MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.

Browse Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz

Browse More PressRelease:
http://www.prweb.com/search.aspx?search-releases=marketresearchreports.biz


Contact
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: [email protected]